- Investing.com
Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, produces, and sells infusion and non-infusion pharmaceutical products in China. The company offers infusion products; oral medication and other dosage form; medical devices, such as infusion set, dispensing and injection syringes, detained needles, nebulizer, and vacuum blood collection tubes; over-the-counter products; and APIs for treatment of cardiovascular, IPF, ED, anti-tumor, anti-emetic, antibiotic, VB12, anti-rheumatoid arthritis, multiple sclerosis, anti-schizophrenia, CKD and anti-anemia, polypeptide, and other indications. It also provides ambroxol hydrochloride, potassium chloride, sodium chloride, magnesium sulfate, glucose, sterile water, sodium bicarbonate, lidocaine hydrochloride, vitamin B6, ribavirin, ceftazidime, 5% glucose, and ceftriaxone sodium injection. The company was founded in 1996 and is based in Chengdu, the People's Republic of China. Sichuan Kelun Pharmaceutical Co., Ltd. is a subsidiary of Sichuan Kelun Industry Group CO., LTD.
Metrics to compare | 002422 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship002422PeersSector | |
---|---|---|---|---|
P/E Ratio | 22.3x | 28.6x | −0.5x | |
PEG Ratio | −2.44 | −0.86 | 0.00 | |
Price/Book | 2.4x | 2.3x | 2.6x | |
Price / LTM Sales | 2.8x | 3.2x | 3.2x | |
Upside (Analyst Target) | 23.6% | 7.0% | 43.8% | |
Fair Value Upside | Unlock | 4.0% | 5.1% | Unlock |